Clinical Trial Update: Methylphenidate Treatment of Attention Deficits in Epilepsy [Phase 4]

View source ↗

Summary

This update reports results from a Phase 4 trial evaluating methylphenidate for attention deficits in people with epilepsy; the study is completed and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Kimford Jay Meador | Conditions: Epilepsy, Cognitive Deficits | Phase 4 | Status: COMPLETED | Results posted: 2016-08-31